Utama › Narkolepsi › South Carolina
Kajian klinikal Narkolepsi di South Carolina
7 kajian untuk Narkolepsi sedang mencari peserta di lokasi di South Carolina.
Bandar di South Carolina
Teks kajian rasmi (Bahasa Inggeris)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Columbia, South Carolina, Columbia
Mengambil pesertaFasa 2/3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07598708A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Columbia
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07455383A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)
- Bogan Sleep Consultants, Columbia
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07540364A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Lowcountry Lung and Critical Care PA, Charleston
- Medical University of South Carolina, Charleston
- Bogan Sleep Consultants, LLC, Columbia
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07675135A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Columbia
Mengambil pesertaFasa 2/3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06767683A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
- Bogan Sleep Consultants, LLC, Columbia
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Mei 2026 · NCT07493265A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- North Charleston, South Carolina, North Charleston
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 16 Apr 2026 · NCT07096674Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.